Moors & Cabot’s Silver Standard Resources SSRI Stock Holding History

Moors & Cabot’s Portfolio SSRI Stock Details SSRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-18,000	Closed	-$174K	–	564
2017 Q2	$174K	Hold	18,000	–	–	0.03%	479
2017 Q1	$193K	Hold	18,000	–	–	0.03%	468
2016 Q4	$160K	Hold	18,000	–	–	0.03%	493
2016 Q3	$216K	Hold	18,000	–	–	0.04%	460
2016 Q2	$232K	Hold	18,000	–	–	0.04%	425
2016 Q1	$101K	Hold	18,000	–	–	0.02%	485
2015 Q4	$93K	Hold	18,000	–	–	0.02%	474
2015 Q3	$117K	Sell	18,000 -1,500	-8%	-$9.13K	0.02%	466
2015 Q2	$123K	Hold	19,500	–	–	0.02%	486
2015 Q1	$88K	Hold	19,500	–	–	0.01%	487
2014 Q4	$99K	Buy	+19,500	New	+$102K	0.02%	482

Other funds holding SSRI

SCP

Syntal Capital Partners Midland, Texas $10M AUM 35.51% 1-Year Est. Return

Moors & Cabot's SSRI Position: Q3 2017 in Review

Moors & Cabot sold out of Silver Standard Resources (SSRI) in Q3 2017, closing a stake of 18,000 shares — an estimated $174K sold.

Moors & Cabot first reported a position in SSRI in Q4 2014 and held it in 11 quarters. The position peaked at $232K in Q2 2016. 1 fund tracked by Wall St. Rank holds SSRI as of Q3 2017.

Moors & Cabot reported no remaining Silver Standard Resources position as of Q3 2017 after selling out during the quarter.
Moors & Cabot sold 18,000 Silver Standard Resources shares in Q3 2017, an estimated $174K.
Moors & Cabot first reported a position in Silver Standard Resources in Q4 2014 and held it in 11 quarters.
Moors & Cabot's Silver Standard Resources position peaked at $232K in Q2 2016.
1 fund tracked by Wall St. Rank held Silver Standard Resources as of Q3 2017.

Based on Moors & Cabot's 13F filing for Q3 2017, filed 16 Nov 2017.